HEALIONICS CORPORATION

Basic Information

2121 N 35th St
SEATTLE, WA, 98103-9103

Company Profile

n/a

Additional Details

Field Value
DUNS: 801372066
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 7


  1. Biointegrating Dialysis Access Graft with Self Stabilizing Flow

    Amount: $581,096.00

    DESCRIPTION provided by applicant Objective The goals of this Phase II SBIR proposal are to evaluate longer term patency and safety of a novel hemodialysis access graft design ePTFE treated with ...

    SBIR Phase II 2015 Department of Health and Human Services National Institutes of Health
  2. Infection and Thrombosis Resistant Needle-Free Hemodialysis Access Port and Graft Using STAR Biomaterials

    Amount: $579,539.00

    DESCRIPTION provided by applicant Objective The goal of this Direct to Phase II SBIR project is to advance development of a needle free hemodialysis access port device The project stems from prom ...

    SBIR Phase II 2015 Department of Health and Human Services National Institutes of Health
  3. Vascular Grafts for Needle Free Dialysis Access Devices.

    Amount: $224,499.00

    DESCRIPTION (provided by applicant): The objective of this Phase I SBIR proposal is to evaluate a novel vascular graft design for use as the arteriovenous (AV) graft component of a new needle-free acc ...

    SBIR Phase I 2014 Department of Health and Human Services
  4. Fibrosis-Resistant Bleb-Free Gaucoma Implant

    Amount: $206,540.00

    DESCRIPTION (provided by applicant): The objective of this Phase I SBIR project is to test the feasibility of using a novel biomaterial design for improved Glaucoma Drainage Device (GDD) performance. ...

    SBIR Phase I 2014 Department of Health and Human Services
  5. Biointegrated Synthetic Grafts for Reconstruction of Vascular Tissues

    Amount: $149,978.00

    Current vascular repair and replacement grafts made from synthetic biomaterials, typically expanded polytetrafluoroethylene (ePTFE), have poor functionality for use with smaller vessels in the extremi ...

    SBIR Phase I 2014 Department of Defense Defense Health Program
  6. Anti-Infective Dermal Integration Sleeves for Needle Free Dialysis Access Devices

    Amount: $909,165.00

    DESCRIPTION (provided by applicant): Significance: End Stage Renal Disease (ESRD) affects a rapidly growing population likely to exceed 1 million patients in the US by 2020. The standard treatment of ...

    SBIR Phase II 2012 Department of Health and Human Services
  7. Artificial Cornea Using New Biomaterials

    Amount: $116,418.00

    DESCRIPTION (provided by applicant): Artificial Cornea Using New Biomaterials PD/PI Maxwell Maginness PhD Project Summary/Abstract. We propose to advance the development of a novel artificial cornea d ...

    STTR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government